Question follow-through · 26382
Alzheimer's Disease: Medical Treatments
To ask the Secretary of State for Health and Social Care, if he will have discussions with (a) Eisai Co., Ltd and Biogen Inc. and (b) Eli Lilly and Company on the production of disease-modifying treatments for Alzheimer's disease in the UK.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 24 Jan 2025
- Target answer date
- 29 Jan 2025
- Answer
- 30 Jan 2025 · 6 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- General Practitioners: Industrial Action · 27 Jan 2025
- Alzheimer's Disease: Drugs and Health Services · 28 Jan 2025
- Memory Clinics: Oxfordshire · 28 Jan 2025
- Givinostat · 28 Jan 2025
- Caesarean Sections · 28 Jan 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
24 Jan 2025
Question tabled
To ask the Secretary of State for Health and Social Care, if he will have discussions with (a) Eisai Co., Ltd and Biogen Inc. and (b) Eli Lilly and Company on the production of disease-modifying treatments for Alzheimer's disease in the UK.
29 Jan 2025
Target answer date
Date supplied by the official written-questions record.
30 Jan 2025
Answer published
The Government deeply values its relationships with life science companies and is committed to getting treatments to National Health Service patients through our 10 Year Plan for the NHS. This will include a plan for procurement, giving a clearer route to...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
General Practitioners: Industrial Action
27 Jan 2025 · To ask the Secretary of State for Health and Social Care, what steps the Government if taking to reach an agreement to end collective action by GPs.
Alzheimer's Disease: Drugs and Health Services
28 Jan 2025 · To ask the Secretary of State for Health and Social Care, if he will take steps to (a) increase diagnostic capacity at memory clinics, (b) prepare primary care, (c) increase numbers of specialists capable of prescribing new medicines, (d) adopt new diagno
Memory Clinics: Oxfordshire
28 Jan 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of adequacy of the diagnostic capacity of memory clinics in Oxfordshire.
Givinostat
28 Jan 2025 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of expediting a NICE appraisal for Givinostat.
Caesarean Sections
28 Jan 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 January 2025 to Question 24596 on Caesarean Sections, what steps he is taking with NHS England to ensure that women are not unnecessarily discouraged from having electi
Dementia: Diagnosis
5 Feb 2025 · To ask the Secretary of State for Health and Social Care, whether he plans to retain the 66.7% national dementia diagnosis rate target for the 2025-26 financial year.
Givinostat
24 Feb 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure all eligible NHS Trusts participate in the Early Access Programme for givinostat.
Ambulance Services: Henley and Thame
24 Feb 2025 · To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of the provision of ambulance services by South Central Ambulance Service in Henley and Thame constituency.
Givinostat
26 Feb 2025 · To ask the Secretary of State for Health and Social Care, whether he has had discussions with (a) NHS England and (b) ITF Pharma UK on the (i) resources and (ii) guidance available to NHS Trusts that participate in the early access programme for givinosta
Givinostat
26 Feb 2025 · To ask the Secretary of State for Health and Social Care, if he will have discussions with (a) Duchenne UK and (b) other patient advocacy groups on steps to increase access to the givinostat early access programme.
Heart Diseases: Young People
27 Feb 2025 · To ask the Secretary of State for Health and Social Care, what comparative assessment he has made of levels of young people dying from sudden cardiac death in (a) England and (b) other European countries; and what steps he plans to take to reduce levels o
Paediatric Acute-onset Neuropsychiatric Syndrome and Paediatric Autoimmune Neuropsychiatric Disorders: Research
27 Feb 2025 · To ask the Secretary of State for Health and Social Care, with reference to the meeting between PANS PANDAS and his Department on 19 November 2024, what recent assessment he has made of the adequacy of funding for research into that condition.